v3.26.1
Revenue Recognition
 12 Months Ended
Dec. 31, 2025
Revenue Recognition [Abstract]  
REVENUE RECOGNITION

NOTE 3 – REVENUE RECOGNITION

 

The Company recognizes revenue when it satisfies a performance obligation by transferring control over a product to a customer or as services are performed. Revenue is measured based on the consideration the Company receives in exchange for those products

 

The following table presents the Company’s revenue by product category for the years ended December 31, 2025, and 2024:

 

   For the Years Ended
December 31,		 
   2025   2024 
Training  $1,125,521   $809,654 
Product supplies   2,024,573    1,748,961 
Equipment   75,835    177,225 
Patient procedures   1,874,386    1,371,654 
Total revenue  $5,100,315   $4,107,494 

 

Listed below are the revenues, cost of revenues, gross profits, assets and net loss by Company:

 

   For the Year Ended 
   December 31, 2025 
   Global Stem   Meso     
   Cells Group   Numismatics   Total 
Revenue  $5,100,315   $
-
   $5,100,315 
Cost of revenue   2,289,537    
-
    2,289,537 
Gross profit  $2,810,778   $
-
   $2,810,779 
Gross Profit %   54.73%   0.00%   54.73%
                
Assets  $2,718,911   $1,769,783   $4,488,694 
Net income (loss)  $(742,221)  $(7,070,188)  $(7,812,409)